Long-term opioid use fails to alleviate chronic back pain, Northwestern University study suggests
Researchers identified distinct brain activity patterns and molecular markers that may guide future treatments for pain management and opioid tapering.
A recent investigation conducted by Northwestern University suggests that extended use of prescription opioids does not appear to decrease pain levels or enhance physical functioning for individuals suffering from chronic back pain. Published in the journal Brain on October 1, the study compared the experiences and neurological profiles of long-term opioid users against a control group of similar patients who do not use the medication.
Comparative outcomes for chronic pain patients
The research team analyzed two distinct groups of participants, both of whom suffered from chronic back pain. The first group consisted of 70 individuals who had been using prescription opioids daily for an average of 7.8 years. The second group included 70 closely matched patients who were not using opioids to manage their condition. According to the study, both groups reported nearly the same level of pain, averaging approximately 5.4 on a 10-point scale.
While pain levels remained similar, the researchers noted that the group using opioids experienced slightly lower scores regarding their mental health and physical functionality. However, A. Vania Apkarian, the director of the Center for Translational Pain Research at Northwestern University Feinberg School of Medicine and a senior author of the study, noted that the psychological and neurological properties of the opioid-using participants remained largely intact. Apkarian suggested that these findings may address contemporary concerns regarding whether opioid ingestion causes drastic changes to brain structure, noting that the participants in this study were all taking low or moderate doses under the supervision of medical professionals.
Neurological shifts and molecular signatures
To investigate how long-term medication affects the brain, the scientists utilized functional MRI technology to monitor changes in blood flow, which serves as a measure of brain activity. The study found no significant evidence that years of opioid use had altered the physical anatomy of the brain. However, the researchers observed significant differences in spontaneous brain activity and the way different brain regions communicate.
These functional differences were particularly prominent in the prefrontal cortex, a region associated with decision-making, and the mesocorticolimbic network, which is involved in motivation and reward systems. To analyze these patterns, the research team developed a new computational method that integrated MRI data with established brain maps of neurotransmitter receptors. This approach allowed them to identify specific molecular signatures related to long-term opioid use and various aspects of chronic pain.
The study identified that these molecular markers involved activity within opioid and serotonin receptors. Apkarian indicated that identifying these specific brain states is a significant development, as it provides potential indicators for determining which pharmaceutical treatments might be effective and which should be avoided in the future.
Potential for new treatment pathways
The identification of these molecular markers may have implications for both pain management and the process of reducing opioid dependency. The researchers also observed a subset of 21 patients who had finished a four-week rehabilitation program for pain. Within this small group, eight individuals successfully decreased their opioid consumption by more than 30%. The brain activity of these patients showed changes linked to the previously identified serotonin and opioid receptors, which the researchers believe supports the idea that these markers could help guide future clinical interventions.
Based on the discovery of the serotonin molecular pathway, the Northwestern scientists intend to investigate whether certain antidepressants can be utilized to treat chronic pain and assist patients in tapering off opioids. This research follows the context of a significant public health issue, as approximately 5 million adults in the United States regularly use prescription opioids for chronic pain management.
Study limitations and context
The researchers emphasized that the study was the first to specifically examine the relationship between long-term opioid consumption and brain properties. While the study did not show that opioids improved pain, it also did not demonstrate that the long-term users were significantly worse off than the non-users in terms of overall neurological health. The findings serve as a foundation for future testing of drugs that target the specific molecular pathways identified during this investigation.
Source: Medical Xpress. Prepared with AI assistance from the linked reporting.
More in Health & Nutrition
- Human tau seeds trigger disease-specific shapes in mouse brains, new study finds
Study in Nature shows that injectable human tau aggregates from Alzheimer’s and corticobasal degeneration template their 3D folds onto mouse tau, supporting the prion-like seeding model.
- Menopause Largely Missing from Electronic Health Records Despite Its Health Impact
study of nearly 240,000 women finds only 12% of electronic records include menopause status, even though over half reported being in transition.
- Brain circuit linking amygdala and dorsolateral striatum implicated in OCD
Study in Neuron identifies a previously unknown neural pathway that amplifies sensory-driven behaviors in a mouse model of OCD, offering new targets for precise interventions.